![20th Anniversary - Logos [RGB]_Growth](/media/131950/20th-anniversary-logos-rgb-_growth.png)
- Sign up for latest news
- Send us an email
- Call +44 (0)20 8069 5000
- London
- Lyon
- Singapore
- Boston
- New York
- Philadelphia
- San Francisco
Our people
Our 130+ market research consultants, located across our 6 global offices, are committed to providing a high quality service, intelligent thinking, market research expertise and therapy knowledge on every project
We recognise that our people are our business
Between them, our senior team have more than 400 years of market research experience. We have specialists in quantitative and qualitative research, emerging markets experts, innovators of digital research techniques, patient advocates and market understanding gurus. Our researchers come from a range of educational backgrounds in the sciences, arts and humanities and speak over 20 languages, including Greek, Swedish, French, Czech and Dutch.
We love research and have a passion for healthcare
But we also like travelling the world, baking cakes, strumming guitar, writing books, playing hockey, DJ’ing and sailing boats. That’s just us.
Find out what more about our people and what it’s like to work here in our short film. »
- Some example case studiesHow buyer insights guided the development of an effective market strategy for a HIV product
The challengeOur client was developing a new product for HIV and needed to understand buyer willingness to pay in the emerging markets of South Africa, Kenya, and India. They needed to understand how new medicines are added to the guidelines and how they are evaluated and funded. They also needed to gain an understanding of stakeholders’ reactions to their product, the drivers and barriers to…
read more »How scenario testing helped assess demand for a brand launch in the fragmented NSCLC marketThe challengeOur client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led by established 1st generation tyrosine kinase inhibitors (TKIs). There were several scenarios that the client wanted to test, including impact of launch order and the impact of future 3rd generation TKIs on the drug’s…
read more »How we applied user-led design thinking in the ER setting to improve patient careThe challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a burden and antibiotic resistance is a key issue, which sometimes results in families needing to seek emergency hospital attention in response to acute pain. We interviewed urgent care and ER physicians in order to find…
read more » - Our latest awardsResearch Partnership and Janssen are 2017-18 BOBI Awards finalists
We are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI (Best of Business Intelligence) Awards for our combined work in helping to reverse the fortunes of one of their established products, which up until recently had been suffering from declining market growth in the UK.…
read more »Director Richard Head is joint winner of the 2017 EphMRA President's AwardWe are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President's Award for his contribution to pharmaceutical market research.
read more »Richard Head elected Associate Member to the EphMRA BoardWe are pleased to announce that Director Richard Head has been re-elected to the EphMRA Executive Board 2015 following a vote by other Associate Members.
read more »